Zai Lab Limited (ZLAB) Estados Financieros e Histórico

Zai Lab Limited (ZLAB) — Precio $24.67 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Zai Lab Limited (ZLAB): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Zai Lab Limited registró ingresos de $460.2M en el último ejercicio fiscal, con un CAGR de 5 años del 56.5%.

Márgenes de los últimos 12 meses: margen bruto 58.5%, margen operativo -48.6%, margen neto -38.1%.

Al precio actual de $24.67, ZLAB presenta beneficios negativos (P/E no significativo) y un ROE del -24.53%. La capitalización bursátil es de $2.8B.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos00$129452$13.0M$49.0M$144.3M$215.0M$266.7M$399.0M$460.2M
Coste de Ventas00$43590$3.7M$239.4M$52.2M$74.0M$95.8M$147.9M$191.1M
Beneficio Bruto00$85862$9.2M-$190.5M$92.1M$141.0M$170.9M$251.1M$269.1M
I+D$32.1M$39.3M$120.3M$142.2M$222.7M$573.3M$286.4M$265.9M$234.5M$220.9M
Generales y Administrativos$6.4M$12.0M$21.6M$70.2M$111.3M$218.8M$259.0M$281.6M$298.7M$277.6M
Gastos Operativos$38.5M$51.4M$141.9M$212.4M$111.3M$792.1M$545.4M$537.5M$533.2M$492.6M
Beneficio Operativo-$38.5M-$51.4M-$141.8M-$203.2M-$301.8M-$700.1M-$404.4M-$366.6M-$282.1M-$223.6M
EBITDA-$38.3M-$50.8M-$138.4M-$190.3M-$297.2M-$689.5M-$434.8M-$365.1M-$234.6M-$158.2M
Gastos por Intereses00$39672$293000$181000000$2.3M$5.2M
Beneficio Antes de Impuestos-$37.5M-$50.1M-$138.5M-$206.0M-$268.9M-$703.4M-$443.3M-$334.6M-$257.1M-$178.5M
Impuestos0$477699$3.3M-$11.0M0$1.1M000-$2.9M
Beneficio Neto-$37.5M-$50.4M-$139.1M-$195.1M-$268.9M-$704.5M-$443.3M-$334.6M-$257.1M-$175.5M
BPA$-39.70$-23.20$-26.40$-30.30$-34.60$-75.80$-46.30$-34.60$-2.60$-1.60
BPA Diluido$-39.70$-23.20$-26.40$-30.30$-34.60$-75.80$-46.30$-34.60$-2.60$-1.60
Acciones en Circulación (Diluidas)$943902$2.2M$5.3M$6.4M$7.8M$9.3M$9.6M$9.7M$98.9M$109.5M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$116.1M$127.6M$99.6M$106.3M
Beneficio Bruto$69.2M$65.3M$61.3M$58.1M
Beneficio Operativo-$48.8M-$69.4M-$69.3M-$76.5M
EBITDA-$30.7M-$48.1M-$44.0M-$46.1M
Beneficio Neto-$36.0M-$50.4M-$51.0M-$50.8M
BPA$-0.33$-0.46$-0.50$-0.50
BPA Diluido$-0.33$-0.46$-0.50$-0.50

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$83.9M$229.7M$63.0M$75.9M$442.1M$964.1M$1.01B$790.2M$449.7M$679.6M
Inversiones a Corto00$200.3M$200.0M$744.7M$445.0M0$16.3M$330.0M$10.0M
Cuentas por Cobrar00$90000$3.8M$5.2M$54.8M$48.6M$65.3M$89.4M$106.1M
Inventario00$3822$6.0M$13.1M$19.0M$31.6M$44.8M$39.9M$74.7M
Activos Corrientes$84.1M$230.6M$269.1M$292.5M$1.22B$1.50B$1.12B$939.6M$1.05B$1.02B
Inmovilizado Material$2.7M$12.0M$20.8M$36.9M$47.1M$58.3M$78.8M$68.7M$69.5M$66.5M
Fondo de Comercio0000000000
Activos Intangibles$7000$20089$321566$8.8M$9.4M$9.7M$8.4M$16.5M$58.9M$76.1M
Activos Totales$88.9M$249.6M$302.0M$355.2M$1.30B$1.61B$1.22B$1.04B$1.19B$1.17B
Cuentas por Pagar$523337$9.0M$37.4M$22.7M$62.6M$126.2M$66.0M$113.0M$100.9M$141.6M
Deuda a Corto00$3.6M$6.5M0000$131.7M$204.5M
Pasivos Corrientes$5.2M$12.1M$48.8M$46.6M$98.0M$192.9M$139.8M$203.1M$299.4M$416.2M
Deuda a Largo000000000$13.4M
Pasivos Totales$140.5M$14.5M$50.9M$60.5M$128.3M$230.0M$174.5M$240.2M$344.9M$456.9M
Reservas-$60.2M-$110.6M-$249.6M-$444.7M-$713.6M-$1.42B-$1.86B-$2.20B-$2.45B-$2.63B
Patrimonio Neto-$51.6M$235.2M$251.1M$294.7M$1.17B$1.38B$1.05B$796.1M$840.9M$715.5M
Deuda Total00$3.6M$21.8M$18.6M$15.5M$20.4M$15.2M$153.5M$224.3M
Deuda Neta-$83.9M-$229.7M-$259.7M-$254.2M-$1.17B-$1.39B-$988.1M-$791.3M-$626.2M-$465.3M
Capital Circulante$78.9M$218.5M$220.3M$245.8M$1.12B$1.31B$984.5M$736.5M$751.1M$603.1M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$717.2M$679.6M$651.3M$607.5M
Activos Totales$1.16B$1.17B$1.10B$1.07B
Pasivos Totales$399.0M$456.9M$433.8M$467.8M
Patrimonio Neto$759.9M$715.5M$662.0M$607.0M
Deuda Total$219.4M$224.3M$231.9M$254.6M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$37.5M-$50.4M-$139.1M-$195.1M-$268.9M-$704.5M-$443.3M-$334.6M-$257.1M-$175.5M
Amortizaciones$199005$548127$1.6M$3.8M$4.6M$6.5M$8.2M$9.0M$11.9M$15.0M
Compensación en Acciones$4.9M$9.9M$12.2M$20.3M$24.8M$40.7M$61.3M$79.6M$70.7M$65.6M
Cambio en Capital Circulante-$1.7M$7.5M$27.4M-$23.3M$18.2M$23.1M-$66.2M$39.6M-$68.4M-$54.7M
Flujo de Caja Operativo-$32.2M-$32.4M-$97.5M-$191.0M-$216.1M-$549.2M-$367.6M-$198.2M-$214.9M-$150.8M
Inversiones (CapEx)-$2.2M-$9.1M-$10.1M-$15.2M-$10.7M-$18.9M-$25.0M-$8.5M-$61.5M-$13.4M
Adquisiciones0-$1.9M-$2.1M$9.2M$539000-$30.0M00$289990
Recompra de Acciones0000000000
Dividendos Pagados0000000000
Flujo de Caja Libre-$34.4M-$41.5M-$107.7M-$206.3M-$226.7M-$568.2M-$392.6M-$206.7M-$276.4M-$164.2M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo-$32.0M-$26.0M-$11.9M-$63.4M
Inversiones (CapEx)-$4.1M-$1.3M-$22.3M-$1.5M
Flujo de Caja Libre-$36.1M-$27.3M-$34.2M-$64.9M
Dividendos Pagados0000
Compensación en Acciones$16.9M$15.9M$13.5M$11.9M

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)+9930.6%+277.0%+194.8%+49.0%+24.0%+49.6%+15.3%
Crecimiento Beneficio Neto (anual)-34.3%-176.0%-40.3%-37.8%-162.0%+37.1%+24.5%+23.2%+31.7%
Crecimiento BPA (anual)+41.6%-13.8%-14.8%-14.2%-119.1%+38.9%+25.3%+92.5%+38.5%
Cambio en Acciones (anual)+130.5%+141.9%+22.4%+20.7%+19.7%+3.0%+0.9%+923.9%+10.7%
Crecimiento FCF (anual)-20.6%-159.5%-91.6%-9.9%-150.6%+30.9%+47.4%-33.7%+40.6%
Margen Bruto66.3%71.1%-389.1%63.8%65.6%64.1%62.9%58.5%
Margen Operativo-109514.0%-1564.9%-616.4%-485.1%-188.0%-137.4%-70.7%-48.6%
Margen EBITDA-106949.8%-1465.3%-607.0%-477.8%-202.2%-136.9%-58.8%-34.4%
Margen Neto-107433.6%-1502.3%-549.3%-488.2%-206.1%-125.5%-64.4%-38.1%
Margen FCF-83162.8%-1588.4%-463.1%-393.7%-182.6%-77.5%-69.3%-35.7%
Tasa Impositiva Efectiva-0.0%-1.0%-2.4%5.3%-0.0%-0.2%-0.0%-0.0%-0.0%1.6%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-36.43$-19.07$-20.46$-32.04$-29.19$-61.10$-40.98$-21.39$-2.79$-1.50
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$943902$2.2M$5.3M$6.4M$7.8M$9.3M$9.6M$9.7M$98.9M$109.5M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital-24.53%
Rentabilidad sobre capital invertido-22.74%
Rentabilidad sobre activos-14.97%
Margen bruto58.47%
Margen operativo-48.59%
Margen neto-38.15%

Salud financiera

Deuda / Patrimonio0.31
Ratio corriente2.45
Piotroski F-Score3
Altman Z-Score-0.22

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-0.70-0.96-0.88-1.37-3.91-0.83-0.66-0.79-10.07-11.03
P/VC-0.510.210.490.910.900.420.280.333.082.70
P/V0.000.00943.6720.6221.474.051.370.996.504.20
Margen Bruto0.0%0.0%66.3%71.1%-389.1%63.8%65.6%64.1%62.9%58.5%
Margen Operativo0.0%0.0%-109514.0%-1564.9%-616.4%-485.1%-188.0%-137.4%-70.7%-48.6%
Margen Neto0.0%0.0%-107433.6%-1502.3%-549.3%-488.2%-206.1%-125.5%-64.4%-38.1%

Empresas relacionadas: AAPG · APGE · CDTX · CNTA · IDYA · IRON · LEGN

Explorar sector: Healthcare · Biotechnology

Más secciones de ZLAB: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones